Cat. No. | Name/Description | Purity |
---|---|---|
A165759 | AZD-7762 | 98+% |
A853008 | Prexasertib | 98% |
A1177301 | Prexasertib Mesylate Hydrate | 98% |
A141550 | Rabusertib | 98% |
A200833 | SCH900776 | 98+% |
A690852 | GDC-0575 | 98+% |
A144417 | BML-277 | 98% |
A191306 | Prexasertib 2HCl | 98% |
A433196 | CCT245737 | 97+% |
A465968 | SB-218078 | 98% |
A119534 | Chk2-IN-1 | 95+% |
A1365457 | Chk1-IN-5 | 98% |
A1176700 | CHK1-IN-2 | 99+% |
A1361702 | Prexasertib dimesylate | 98% |
A869154 | SCH900776 (S-isomer) | 98+% |
A1483415 | PV1115 | 98% |
A415147 | MU380 | 99+% |
A525147 | PV-1019 | 95% |
A359994 | GDC-0425 | 99+% |
A1177764 | CHK-IN-1 |
Name/Description | Chk1 ↓ ↑ | Chk2 ↓ ↑ | Other Targets | Purity | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Rabusertib |
++
Chk1, IC50: 7 nM |
99%+ | |||||||||||||||||
PF-477736 |
++++
Chk1, Ki: 0.49 nM |
98% | |||||||||||||||||
CHIR-124 |
++++
Chk1, IC50: 0.3 nM |
PDGFR,GSK-3,FLT3 | 98+% | ||||||||||||||||
SCH900776 |
+++
Chk1, IC50: 3 nM |
99%+ | |||||||||||||||||
SAR-020106 |
+
Chk1, IC50: 13.3 nM |
98% | |||||||||||||||||
CCT245737 |
+++
Chk1, IC50: 1.4 nM |
97+% | |||||||||||||||||
Prexasertib 2HCl |
++++
Chk1, Ki: 0.9 nM |
++
Chk2, IC50: 8 nM |
RSK | 99%+ | |||||||||||||||
BML-277 |
+
Chk2, IC50: 15 nM |
99%+ | |||||||||||||||||
AZD-7762 |
+++
Chk1, IC50: 5 nM |
++
Chk2, IC50: <10 nM |
99%+ | ||||||||||||||||
1. Hovering the mouse over the "+" can display the specific value of the relevant IC50. The more "+", the stronger the inhibitory effect. 2. "✔" Indicates that the compound has inhibitory effects on the corresponding subtypes, but there is currently no relevant data on the intensity of inhibition. |